New research out this month suggests that medical cannabis is extremely prevalent among patients looking to treat symptoms for a serious tissue disorder.
The study, which will be published in the American Journal of Medical Genetics, found that more than one-third of patients diagnosed with Ehlers-Danlos syndrome (EDS) have used marijuana to manage symptoms.
NORML, which reported on the study last week, said that the researchers found that 37 percent “reported having used cannabis therapeutically,” with cannabis use particularly prevalent “among patients who reported experiencing either moderate or severe pain.”
“Of all of the traditional and complementary therapies used by respondents, ‘marijuana was self-rated as most effective,’” NORML noted in its write-up.
What is EDS?
The National Institute of Health defines Ehlers-Danlos syndrome as “a group of disorders that affect connective tissues supporting the skin, bones, blood vessels, and many other organs and tissues,” the outlook for which can “range from mildly loose joints to life-threatening complications.” The hallmark symptoms of Ehlers-Danlos syndrome are extremely flexible joints and elastic-like skin that is susceptible to bruising.
According to the NIH, Ehlers-Danlos syndrome “appears to be at least 1 in 5,000 individuals worldwide.”
The research published in the Journal of Medical Genetics, which was subsidized with grant support from University of Colorado Center for Innovative Design and Analysis, was based